45 results
Page 2 of 3
PRE 14A
9iuuc jlbzcjnhq
30 Sep 22
Preliminary proxy
4:45pm
8-K
egy2vr54 wjj
24 Jan 22
Entry into a Material Definitive Agreement
8:00am
424B3
zzsyx iwtkodfdfnj3ps
14 Jan 22
Prospectus supplement
5:18pm
424B5
48bhjb ztcl9
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
3tupgzqdx63ysrq
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
1xjiigpfhyhn rosl1
22 Nov 21
Definitive proxy
4:37pm
424B5
9qr5bst
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
u45bnz e87
14 May 21
Quarterly report
4:31pm
10-K
wll1e c8td
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
kv35uqi3sldy 08emmz
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-99.1
u09wxt2j73ijnei5
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
e7watfe4sv3sam7f0
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
lw1xviccqz evwbsi
2 Nov 20
Prospectus supplement
12:00am